Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in Japanese Adults With Chronic Immune Thrombocytopenia
NCT05369208Phase 3Completed
- Sponsor
- Sobi
- Start
- Jun 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avatrombopag in immune thrombocytopenia (ITP), sponsored by Sobi. Started Jun 2022; status: completed.
02
Drugs
avatrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05369208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05369208.